ALOX5 and inflammation: These findings coupled with the observations that LTB4 is proinflammatory in human UC and that drugs containing 5-ASA inhibit LTB4 production and colonic inflammation in UC led us to hypothesize that 5-ASA may also inhibit toxin A colitis by inhibiting 5-LO in the rat colon.